We improve patient lives by unlocking the tissue phenome.
In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer.
Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com.
|
|
|
|
|
11-50 employees
View all Definiens, The Tissue Phenomics Company employees
|
|
|
Biotechnology
|
|
|
Bernhard-Wicki-Strasse 5, Munich, DE
|
|
|
1994
|
|
|
Clinical Trials, Data Mining, Oncology, Companion Diagnostics, Digital Pathology, Translational Research, Clinical Diagnostics, Drug Discovery And Development, Tissue Diagnostics, Automated Image Analysis, Biomedical Image Analysis Software, Tissue-Based Biomarkers
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.